Stocks · Health care · Biological Products, (No Diagnostic Substances)

Hemab Therapeutics Holdings, Inc.

COAG
United States Fiscal year ends December CIK 0002114044
$31.62 +2.36% Close, 9 Oct 2026
Price $31.62 −15.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 1 May 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for COAG. They arrive with the nightly refresh; a company joins the screen the first time one is.